These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7772289)

  • 41. Antibiotic discovery in the twenty-first century: current trends and future perspectives.
    Donadio S; Maffioli S; Monciardini P; Sosio M; Jabes D
    J Antibiot (Tokyo); 2010 Aug; 63(8):423-30. PubMed ID: 20551985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Fosfomycin. I. Antimicrobial action in vitro].
    Carlone NA; Cuffini AM; Cattaneo O
    G Batteriol Virol Immunol; 1977; 70(1-6):100-7. PubMed ID: 614140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enzybiotics: a look to the future, recalling the past.
    Veiga-Crespo P; Ageitos JM; Poza M; Villa TG
    J Pharm Sci; 2007 Aug; 96(8):1917-24. PubMed ID: 17518365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biochemistry active substances from microorganisms. IV. Establishment of several in vitro anti-inflammatory probes applicable to microbial broths the effects of non-steroidal anti-inflammatory drugs and antibiotics on them.
    Ninomiya YT; Yamada Y; Onitsuka M; Tanaka Y; Maeda T; Maruyama HB
    Chem Pharm Bull (Tokyo); 1980 Sep; 28(9):2553-64. PubMed ID: 7460091
    [No Abstract]   [Full Text] [Related]  

  • 45. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chapter 1. Approaches to discovering novel antibacterial and antifungal agents.
    Donadio S; Monciardini P; Sosio M
    Methods Enzymol; 2009; 458():3-28. PubMed ID: 19374977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Synergic action of the combination of fosfomycin and kanendomycin against gram-positive and gram-negative bacteria].
    Russo G; Toscano MA; Gismondo MR; Nicolosi V; Garaci E
    Ann Sclavo; 1980; 22(1):77-82. PubMed ID: 7247487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of Antibiotics.
    Kalesse M; Böhm A; Kipper A; Wandelt V
    Curr Top Microbiol Immunol; 2016; 398():419-445. PubMed ID: 27704271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotics of choice against Bacteroides fragilis.
    Bittner J; Voinescu V; Munteanu V; Antohi M; Ardeleanu J
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):213-8. PubMed ID: 7159211
    [No Abstract]   [Full Text] [Related]  

  • 50. Francis Tally and the discovery and development of tigecycline: a personal reminiscence.
    Projan SJ
    Clin Infect Dis; 2010 Jan; 50 Suppl 1():S24-5. PubMed ID: 20067389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Fosfomycin, lysine-fosfomycin, arginine-fosfomycin: antibacterial activity in vitro].
    Angeretti A; Martinetto P; Valtz A
    G Batteriol Virol Immunol; 1980; 73(7-12):272-80. PubMed ID: 6796449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
    Thomson CJ; Power E; Ruebsamen-Waigmann H; Labischinski H
    Curr Opin Microbiol; 2004 Oct; 7(5):445-50. PubMed ID: 15451498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of subinhibitory concentrations of fosfomycin on bacteria.
    Lorian V; Atkinson B
    G Ital Chemioter; 1977; 23(2):65-74. PubMed ID: 342326
    [No Abstract]   [Full Text] [Related]  

  • 54. [Use of multidiscs for determination of polyresistance of microorganisms to antibiotics (author's transl)].
    Antal M; Paulíková B; Janousková J; Krcméry V; Stĕpánková E; Baláziková M
    Cesk Epidemiol Mikrobiol Imunol; 1975 May; 24(3):129-35. PubMed ID: 126810
    [No Abstract]   [Full Text] [Related]  

  • 55. The pleuromutilin antibiotics: a new class for human use.
    Novak R; Shlaes DM
    Curr Opin Investig Drugs; 2010 Feb; 11(2):182-91. PubMed ID: 20112168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Microbiology and medical industry].
    Tuzhilkin IM
    Antibiotiki; 1970 Jul; 15(7):579-86. PubMed ID: 4920967
    [No Abstract]   [Full Text] [Related]  

  • 57. Patents, antibiotics, and autarky in Spain.
    Romero De Pablos A
    Med Secoli; 2014; 26(2):423-49. PubMed ID: 26054209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A method of screening for antibiotics producing oxygen radicals.
    Matsuda Y; Kitahara M; Maeda K; Umezawa H
    J Antibiot (Tokyo); 1982 Jul; 35(7):928-30. PubMed ID: 7174543
    [No Abstract]   [Full Text] [Related]  

  • 59. Compound screening: Fresh hunting ground.
    McGilvray A
    Nature; 2016 May; 533(7602):S65-7. PubMed ID: 27167395
    [No Abstract]   [Full Text] [Related]  

  • 60. Protein synthesis and antibiotics. Dedicated to the memory of David Vázquez. Part I. Action of antibiotics.
    Biochimie; 1987 Aug; 69(8):795-04. PubMed ID: 3122842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.